KPMA vice chairman stressed to minimize Korea/America FTA impact

Published: 2006-03-08 07:00:00

Updated: 2006-03-08 07:00:00

"The issue on the Korea and U. S. free trade agreement raised a hectic impact to the pharmaceutical industry in terms of the influx of many generic drugs and the drug pricing changes. The KPMA should prepare how to cope with the challenge in March" the new vice chairman Moon Kyung-tae of KPMA sai...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK